Aprotinin Market Report – Research, Industry Analysis Reports and Market Demands

Global Aprotinin Market Insights, Forecast to 2025

Request for Sample of this report

Buy now

Table of Content

1 Study Coverage

1.1 Aprotinin Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
- 1.4.1 Global Aprotinin Market Size Growth Rate by Product
- 1.4.2 Aprotinin (From bovine lung)
- 1.4.3 Recombinant Aprotinin
1.5 Market by End User
- 1.5.1 Global Aprotinin Market Size Growth Rate by End User
- 1.5.2 Pharmaceuticals
- 1.5.3 Scientific Research & Experiment
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary

2.1 Global Aprotinin Market Size
- 2.1.1 Global Aprotinin Revenue 2014-2025
- 2.1.2 Global Aprotinin Sales 2014-2025
2.2 Aprotinin Growth Rate by Regions
- 2.2.1 Global Aprotinin Sales by Regions
- 2.2.2 Global Aprotinin Revenue by Regions

3 Breakdown Data by Manufacturers

3.1 Aprotinin Sales by Manufacturers
- 3.1.1 Aprotinin Sales by Manufacturers
- 3.1.2 Aprotinin Sales Market Share by Manufacturers
- 3.1.3 Global Aprotinin Market Concentration Ratio (CR5 and HHI)
3.2 Aprotinin Revenue by Manufacturers
- 3.2.1 Aprotinin Revenue by Manufacturers (2014-2019)
- 3.2.2 Aprotinin Revenue Share by Manufacturers (2014-2019)
3.3 Aprotinin Price by Manufacturers
3.4 Aprotinin Manufacturing Base Distribution, Product Types
- 3.4.1 Aprotinin Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Aprotinin Product Type
- 3.4.3 Date of International Manufacturers Enter into Aprotinin Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

4.1 Global Aprotinin Sales by Product
4.2 Global Aprotinin Revenue by Product
4.3 Aprotinin Price by Product

5 Breakdown Data by End User

5.1 Overview
5.2 Global Aprotinin Breakdown Data by End User

6 North America

6.1 North America Aprotinin by Countries
- 6.1.1 North America Aprotinin Sales by Countries
- 6.1.2 North America Aprotinin Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
6.2 North America Aprotinin by Product
6.3 North America Aprotinin by End User

7 Europe

7.1 Europe Aprotinin by Countries
- 7.1.1 Europe Aprotinin Sales by Countries
- 7.1.2 Europe Aprotinin Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
7.2 Europe Aprotinin by Product
7.3 Europe Aprotinin by End User

8 Asia Pacific

8.1 Asia Pacific Aprotinin by Countries
- 8.1.1 Asia Pacific Aprotinin Sales by Countries
- 8.1.2 Asia Pacific Aprotinin Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
8.2 Asia Pacific Aprotinin by Product
8.3 Asia Pacific Aprotinin by End User

9 Central & South America

9.1 Central & South America Aprotinin by Countries
- 9.1.1 Central & South America Aprotinin Sales by Countries
- 9.1.2 Central & South America Aprotinin Revenue by Countries
- 9.1.3 Brazil
9.2 Central & South America Aprotinin by Product
9.3 Central & South America Aprotinin by End User

10 Middle East and Africa

10.1 Middle East and Africa Aprotinin by Countries
- 10.1.1 Middle East and Africa Aprotinin Sales by Countries
- 10.1.2 Middle East and Africa Aprotinin Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
10.2 Middle East and Africa Aprotinin by Product
10.3 Middle East and Africa Aprotinin by End User

11 Company Profiles

12 Future Forecast

12.1 Aprotinin Market Forecast by Regions
- 12.1.1 Global Aprotinin Sales Forecast by Regions 2019-2025
- 12.1.2 Global Aprotinin Revenue Forecast by Regions 2019-2025
12.2 Aprotinin Market Forecast by Product
- 12.2.1 Global Aprotinin Sales Forecast by Product 2019-2025
- 12.2.2 Global Aprotinin Revenue Forecast by Product 2019-2025
12.3 Aprotinin Market Forecast by End User
12.4 North America Aprotinin Forecast
12.5 Europe Aprotinin Forecast
12.6 Asia Pacific Aprotinin Forecast
12.7 Central & South America Aprotinin Forecast
12.8 Middle East and Africa Aprotinin Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

14.1 Value Chain Analysis
14.2 Aprotinin Customers
14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
16.2 Author Details

Description

Aprotinin, also known as bovine pancreatic Aprotinin inhibitor, BPTI (Trasylol, Bayer) is a protein that is used as medication administered by injection to reduce bleeding during complex surgery, such as heart and liver surgery. Its main effect is the slowing down of fibrinolysis, the process that leads to the breakdown of blood clots. The aim in its use is to decrease the need for blood transfusions during surgery, as well as end-organ damage due to hypotension (low blood pressure) as a result of marked blood loss.
Currently, there are many sales companies in the world Aprotinin industry, especially in India and China. The main market players are Sigma-Aldrich, BeiJing Geyuantianrun Bio-tech, Cayman Chemical, Taj Pharmaceuticals Limited and Guangdong Techpool Bio-pharma. The sale Revenue of Aprotinin is about 123458 K USD in 2015.

North America is the largest consumption region of Aprotinin, with a Revenue market share nearly 20.28% in 2015.

The second consumption place is Europe; following North America with the Revenue market share of 19.66%. China is another important market of Aprotinin, enjoying 17.23% Revenue market share.

Aprotinin is used in Pharmaceuticals and Scientific Research & Experiment areas. Report data showed that 74.04% of the Aprotinin market demand in Pharmaceuticals and 25.96% in Scientific Research & Experiment areas in 2015.

There are three kinds of Aprotinin, which are Aprotinin (From bovine lung) and Recombinant Aprotinin. Aprotinin (From bovine lung) is wildly used in the Aprotinin, with a revenue market share nearly 81.11% in 2015.

Briefly speaking, in the next few years, Aprotinin industry will still be a highly energetic industry. Sales of Aprotinin have brought a lot of opportunities, there will more companies enter into this industry, especially in developing countries.

The global Aprotinin market is valued at 140 million US$ in 2018 and will reach 200 million US$ by the end of 2025, growing at a CAGR of 4.6% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Aprotinin market based on company, product type, end user and key regions.

This report studies the global market size of Aprotinin in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Aprotinin in these regions.
This research report categorizes the global Aprotinin market by top players/brands, region, type and end user. This report also studies the global Aprotinin market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sigma-Aldrich
BeiJing Geyuantianrun Bio-tech
Cayman Chemical
Taj Pharmaceuticals Limited
Guangdong Techpool Bio-pharma
Dadeli
A.S.Joshi&Company
Enzymeking Biotechnology
AdooQ BioScience
ProSpec
Yaxin Biotechnology
AMRESCO
PanReac AppliChem
Runhao

Market size by Product
Aprotinin (From bovine lung)
Recombinant Aprotinin
Market size by End User
Pharmaceuticals
Scientific Research & Experiment

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Aprotinin market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Aprotinin market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Aprotinin companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Aprotinin submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Aprotinin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (g). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Aprotinin market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.